New Delhi, May 11 (PTI) Biocon Ltd on Monday said its arm Biocon Pharma Ltd has received approval from Health Canada for micafungin for injection indicated for treatment of fungal infections. The approval by Health Canada is for micafungin for injection of strengths 50 mg and 100 mg, Biocon said in a regulatory filing. The approved product is indicated for use in adults and children four months and older for treatment of patients with candidemia…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.